These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10636788)
1. Policy forum: genetic technologies. Commercialization of genetic research and public policy. Knoppers BM; Hirtle M; Glass KC Science; 1999 Dec; 286(5448):2277-8. PubMed ID: 10636788 [No Abstract] [Full Text] [Related]
2. Gene patenting and licensing: the role of academic researchers and advocacy groups. Ledbetter DH Genet Med; 2008 May; 10(5):314-9. PubMed ID: 18496028 [TBL] [Abstract][Full Text] [Related]
3. Patenting and licensing in genetic testing: ethical, legal, and social issues. Soini S; Aymé S; Matthijs G; Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-50. PubMed ID: 18557182 [No Abstract] [Full Text] [Related]
4. Bioethics group finds "no objection" to human gene patents. Abbott A Nature; 1996 Oct; 383(6599):368. PubMed ID: 8837755 [No Abstract] [Full Text] [Related]
5. Beyond government intervention: drug companies and bioethics. Dresser R Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855 [No Abstract] [Full Text] [Related]
6. The commercialization of biotechnology. The shifting frontier. Leopold M Ann N Y Acad Sci; 1993 Dec; 700():214-31. PubMed ID: 8109866 [No Abstract] [Full Text] [Related]
7. The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Hogarth S; Javitt G; Melzer D Annu Rev Genomics Hum Genet; 2008; 9():161-82. PubMed ID: 18767961 [TBL] [Abstract][Full Text] [Related]
8. A seat at the table: membership in federal advisory committees evaluating public policy in genetics. Ard CF; Natowicz MR Am J Public Health; 2001 May; 91(5):787-90. PubMed ID: 11344888 [TBL] [Abstract][Full Text] [Related]
9. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research. Caulfield T Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021 [No Abstract] [Full Text] [Related]
10. Gene patents, health care policy and licensing schemes. Caulfield T; von Tigerstrom B Trends Biotechnol; 2006 Jun; 24(6):251-4. PubMed ID: 16621074 [TBL] [Abstract][Full Text] [Related]
11. India prepares research, policy initiatives. Bagla P Science; 1999 Jan; 283(5400):309. PubMed ID: 9925483 [No Abstract] [Full Text] [Related]
13. Disability: a voice in Australian bioethics? Newell C N Z Bioeth J; 2003 Jun; 4(2):15-20. PubMed ID: 15597469 [TBL] [Abstract][Full Text] [Related]
15. Addressing ethical issues in biomedicine: national policy perspectives. Hatfield MO Acad Med; 1994 Jul; 69(7):558-9. PubMed ID: 11644542 [No Abstract] [Full Text] [Related]
16. Patents in genomics and human genetics. Cook-Deegan R; Heaney C Annu Rev Genomics Hum Genet; 2010; 11():383-425. PubMed ID: 20590431 [TBL] [Abstract][Full Text] [Related]
17. Human dignity: a guide to policy making in the biotechnology era? Caulfield T; Brownsword R Nat Rev Genet; 2006 Jan; 7(1):72-6. PubMed ID: 16344853 [TBL] [Abstract][Full Text] [Related]
18. Policy issues. Political issues in the genome era. Jeffords JM; Daschle T Science; 2001 Feb; 291(5507):1249-51. PubMed ID: 11233448 [No Abstract] [Full Text] [Related]
19. [Commercialization of genetic research and its impact on the communication of results]. Cardinal G Health Law J; 1999; 7():35-48, 33. PubMed ID: 11066367 [TBL] [Abstract][Full Text] [Related]
20. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics. Aymé S; Matthijs G; Soini S; Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]